Gemtuzumab Ozogamicin for Relapsed and Refractory Acute Myeloid Leukemia and Myeloid Sarcomas-Reference-Cited by-同舟云学术

Gemtuzumab Ozogamicin for Relapsed and Refractory Acute Myeloid Leukemia and Myeloid Sarcomas

Published:2004-09 Issue:9 Volume:45 Page:1791-1795
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Piccaluga Pier Paolo,Martinelli Giovanni,Rondoni Michela,Malagola Michele,Gaitani Stavroula,Isidori Alessandro,Bonini Alessandro,Gugliotta Luigi,Luppi Mario,Morselli Monica,Sparaventi Giovanni,Visani Giuseppe,Baccarani Michele

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/1042819042000219485

Reference15 articles.

1. New developments in antibody therapy for acute myeloid leukemia

2. Expression of normal myeloid-associated antigens by acute leukemia cells

3. Differences in CD33 Intensity Between Various Myeloid Neoplasms

4. Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

5. Calicheamicin γ 1 I and DNA: Molecular Recognition Process Responsible for Site-Specificity

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of illness of non-hematopoietic stem cell transplant-related hepatic sinusoidal obstruction syndrome: a systematic review;Heliyon;2024-08

2. Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative;Pediatric Blood & Cancer;2024-04-21

3. Lumbalgie als symptoom van een extramedullaire tumor bij acute myeloïde leukemie;Tijdschrift voor Geneeskunde;2024-01-05

4. Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Prognosis of Extramedullary Infiltration Positive t(8;21) Acute Myeloid Leukemia;Annals of Transplantation;2023-11-07